Author Metra, Marco

21 to 40 of 45 Items
  • 2019 Journal Article
    ​ ​Bio‐adrenomedullin as a marker of congestion in patients with new‐onset and worsening heart failure​
    ter Maaten, J. M.; Kremer, D.; Demissei, B. G.; Struck, J.; Bergmann, A.; Anker, S. D.   & Ng, L. L. et al.​ (2019) 
    European Journal of Heart Failure21(6) pp. 732​-743​.​ DOI: https://doi.org/10.1002/ejhf.1437 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Association with outcomes and response to treatment of trimethylamine N‐oxide in heart failure: results from BIOSTAT‐CHF​
    Suzuki, T.; Yazaki, Y.; Voors, A. A.; Jones, D. J.; Chan, D. C.; Anker, S. D.   & Cleland, J. G. et al.​ (2019) 
    European Journal of Heart Failure21(7) pp. 877​-886​.​ DOI: https://doi.org/10.1002/ejhf.1338 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure​
    Emmens, J. E.; ter Maaten, J. M.; Damman, K.; van Veldhuisen, D. J.; de Boer, R. A.; Struck, J. & Bergmann, A. et al.​ (2019) 
    Circulation: Heart Failure12(5).​ DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.118.005544 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment​
    Nauta, J. F.; Hummel, Y. M.; Tromp, J.; Ouwerkerk, W.; van der Meer, P.; Jin, X. & Lam, C. S. et al.​ (2019) 
    European Journal of Heart Failure22(7) pp. 1147​-1155​.​ DOI: https://doi.org/10.1002/ejhf.1632 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study​
    Markousis‐Mavrogenis, G.; Tromp, J.; Ouwerkerk, W.; Devalaraja, M.; Anker, S. D. ; Cleland, J. G. & Dickstein, K. et al.​ (2019) 
    European Journal of Heart Failure21(8) pp. 965​-973​.​ DOI: https://doi.org/10.1002/ejhf.1482 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Geographical location affects the levels and association of trimethylamine N‐oxide with heart failure mortality in BIOSTAT‐CHF: a post‐hoc analysis​
    Yazaki, Y.; Salzano, A.; Nelson, C. P.; Voors, A. A.; Anker, S. D. ; Cleland, J. G. & Lang, C. C. et al.​ (2019) 
    European Journal of Heart Failure21(10) pp. 1291​-1294​.​ DOI: https://doi.org/10.1002/ejhf.1550 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach​
    Hoes, M. F.; Tromp, J.; Ouwerkerk, W.; Bomer, N.; Oberdorf‐Maass, S. U.; Samani, N. J. & Ng, L. L. et al.​ (2019) 
    European Journal of Heart Failure22(11) pp. 2102​-2111​.​ DOI: https://doi.org/10.1002/ejhf.1674 
    Details  DOI  PMID  PMC 
  • 2019 Journal Article
    ​ ​Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study​
    Ferreira, J. P.; Metra, M.; Mordi, I.; Gregson, J.; Ter Maaten, J. M.; Tromp, J. & Anker, S. D.  et al.​ (2019) 
    European Journal of Heart Failure21(1) pp. 112​-120​.​ DOI: https://doi.org/10.1002/ejhf.1323 
    Details  DOI  PMID  PMC 
  • 2019 Journal Article | 
    ​ ​Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation​
    Mordi, I. R.; Santema, B. T.; Kloosterman, M.; Choy, A.-M.; Rienstra, M.; van Gelder, I. & Anker, S. D. et al.​ (2019) 
    Clinical Research in Cardiology, pp. 1​-9​.​ DOI: https://doi.org/10.1007/s00392-018-1409-x 
    Details  DOI  PMID  PMC 
  • 2020 Journal Article
    ​ ​Heart failure in the last year: progress and perspective​
    Tomasoni, D.; Adamo, M.; Anker, M. S.; Haehling, S. ; Coats, A. J. S. & Metra, M.​ (2020) 
    ESC Heart Failure7(6) pp. 3505​-3530​.​ DOI: https://doi.org/10.1002/ehf2.13124 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study​
    Lombardi, C. M.; Ferreira, J. P.; Carubelli, V.; Anker, S. D. ; Cleland, J. G.; Dickstein, K. & Filippatos, G. et al.​ (2020) 
    Clinical Research in Cardiology109(8) pp. 967​-977​.​ DOI: https://doi.org/10.1007/s00392-019-01588-7 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)​
    Anker, S. D ; Butler, J.; Khan, M. S.; Abraham, W. T; Bauersachs, J. ; Bocchi, E. & Bozkurt, B. et al.​ (2020) 
    European Heart Journal41(22) pp. 2109​-2117​.​ DOI: https://doi.org/10.1093/eurheartj/ehaa461 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction​
    ter Maaten, J. M.; Martens, P.; Damman, K.; Dickstein, K.; Ponikowski, P.; Lang, C. C. & Ng, L. L. et al.​ (2020) 
    Clinical Research in Cardiology109(8) pp. 1048​-1059​.​ DOI: https://doi.org/10.1007/s00392-020-01598-w 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT‐CHF​
    Israr, M. Z.; Salzano, A.; Yazaki, Y.; Voors, A. A.; Ouwerkerk, W.; Anker, S. D. & Cleland, J. G. et al.​ (2020) 
    European Journal of Heart Failure22(8) pp. 1486​-1490​.​ DOI: https://doi.org/10.1002/ejhf.1951 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure​
    Boorsma, E. M.; Maaten, J. M.; Damman, K.; Veldhuisen, D. J.; Dickstein, K.; Anker, S. D.   & Filippatos, G. et al.​ (2021) 
    European Journal of Heart Failure,.​ DOI: https://doi.org/10.1002/ejhf.2158 
    Details  DOI 
  • 2021 Journal Article
    ​ ​A year in heart failure: an update of recent findings​
    Stretti, L.; Zippo, D.; Coats, A. J.; Anker, M. S.; Haehling, S.; Metra, M. & Tomasoni, D.​ (2021) 
    ESC Heart Failure8(6) pp. 4370​-4393​.​ DOI: https://doi.org/10.1002/ehf2.13760 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Impaired High‐Density Lipoprotein Function in Patients With Heart Failure​
    Emmens, J. E.; Jia, C.; Ng, L. L.; van Veldhuisen, D. J.; Dickstein, K.; Anker, S. D. & Lang, C. C. et al.​ (2021) 
    Journal of the American Heart Association10(9) art. e019123​.​ DOI: https://doi.org/10.1161/JAHA.120.019123 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF​
    Markousis-Mavrogenis, G.; Tromp, J.; Ouwerkerk, W.; Ferreira, J. P.; Anker, S. D; Cleland, J. G & Dickstein, K. et al.​ (2021) 
    Cardiovascular Research118(8) pp. 1964​-1977​.​ DOI: https://doi.org/10.1093/cvr/cvab235 
    Details  DOI 
  • 2022 Journal Article
    ​ ​Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency​
    Butler, J.; Khan, M. S.; Friede, T.; Jankowska, E. A.; Fabien, V.; Goehring, U. & Dorigotti, F. et al.​ (2022) 
    European Journal of Heart Failure,.​ DOI: https://doi.org/10.1002/ejhf.2478 
    Details  DOI 
  • 2022 Journal Article
    ​ ​Heart failure: an update from the last years and a look at the near future​
    Riccardi, M.; Sammartino, A. M.; Piepoli, M.; Adamo, M.; Pagnesi, M.; Rosano, G. & Metra, M. et al.​ (2022) 
    ESC Heart Failure9(6) pp. 3667​-3693​.​ DOI: https://doi.org/10.1002/ehf2.14257 
    Details  DOI 

Researcher

Sort

issue date

ASC DESC

Items per Page